REVIVA PHARMACEUTICALS HOLDI (RVPH)
US76152G1004 - Common Stock
REVIVA PHARMACEUTICALS HOLDI
NASDAQ:RVPH (11/12/2024, 8:00:02 PM)
Premarket: 1.33 +0.01 (+0.76%)1.32
+0.32 (+32%)
Company Profile
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. The company is headquartered in Cupertino, California and currently employs 15 full-time employees. The company went IPO on 2018-10-18. The firm discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
Company Info
REVIVA PHARMACEUTICALS HOLDI
10080 N Wolfe Road, Suite Sw3-200
Cupertino CALIFORNIA 95014
P: 14085018881
CEO: Laxminarayan Bhat
Employees: 15
Website: https://revivapharma.com/
RVPH News
16 hours ago - ChartmillLet's take a look at the stocks that are in motion in today's session.Let's have a look at the top gainers and losers in the middle of the day of today's session.
7 days ago - Reviva PharmaceuticalsReviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
13 days ago - Reviva PharmaceuticalsReviva to Participate in the UBS Global Healthcare ConferenceCUPERTINO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
a month ago - Reviva PharmaceuticalsReviva to Participate in the 2024 Maxim Healthcare Virtual SummitCUPERTINO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
a month ago - Reviva PharmaceuticalsReviva to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceCUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
2 months ago - Reviva PharmaceuticalsReviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor ConferenceCUPERTINO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
RVPH Twits
Here you can normally see the latest stock twits on RVPH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
